OraSure Technologies | OSUR - 流动资产



金融业
股票价格
USD
资产
USD 360.55M
现金及等价物
USD 160.58M
销售成本
USD 15.43M
流动资产
USD 222.94M
流动负债
USD 25.12M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 317.78M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 264.2M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.07M
贸易债权人
USD 8.4M
应收帐款人
USD 22.2M


流动资产 更改 日
Agilent USD 4.69B 70M 2026-06
AngioDynamics USD 161.35M 4.69M 2025-09
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Bio Techne USD 744.4M 56.35M 2026-06
Bio-Rad Laboratories USD 3.02B 78.4M 2026-06
Bruker USD 2.22B 121.4M 2026-06
Cerus USD 174.38M 7.26M 2025-12
Charles River Laboratories USD 1.53B 40.3M 2026-06
Danaher USD 13.38B 554M 2026-06
Dentsply International USD 1.93B 83M 2026-06
Dexcom USD 4.09B 245.1M 2026-06
Illumina USD 2.83B 96M 2026-06
Integra LifeSciences USD 1.19B 19.46M 2026-06
Intuitive Surgical USD 12.33B 807.5M 2026-06
IQVIA Holdings USD 6.23B 6M 2026-06
Mesa Laboratories USD 105.63M 8.2M 2025-12
Mettler Toledo International USD 1.35B 15.48M 2026-06
Myriad Genetics USD 289M 23.8M 2026-06
OraSure Technologies USD 222.94M 17.84M 2026-06
Quidel USD 1.38B 400K 2026-06
Repligen USD 1.2B 39.19M 2026-06
Revvity USD 2.3B 169.4M 2026-06
STAAR Surgical USD 342.35M 29.96M 2026-06
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
Trinity Biotech USD 35.9M 382K 2025-12
Waters USD 3.9B 186M 2026-06